Moore Capital Management’s AstraZeneca AZN Stock Holding History

Moore Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,000	Closed	-$3.39M	–	451
2023 Q3	$3.39M	Buy	+25,000	New	+$3.41M	0.09%	205
2023 Q2	–	Hold	0	–	–	–	524
2022 Q1	–	Sell	-205,822	Closed	-$24M	–	754
2021 Q4	$24M	Buy	+205,822	New	+$24.2M	0.61%	40
2014 Q4	–	Sell	-30,000	Closed	-$2.14M	–	314
2014 Q3	$2.14M	Sell	30,000 -10,000	-25%	-$732K	0.07%	282
2014 Q2	$2.97M	Buy	+40,000	New	+$2.89M	0.1%	247

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return